Results 11 to 20 of about 3,596 (145)

All that glitters is not gold: A case of lanthanum carbonate aspiration [PDF]

SAGE Open Medical Case Reports, 2017
Introduction: Foreign body aspiration is a significant cause of morbidity and mortality in elderly hospitalized patients. These are typically small items that patients have access to, including small coins.
Suchitra Paranji, Neethi Paranji, Adam S Weltz   +2 more
doaj   +2 more sources

Lanthanum carbonate: safety data after 10 years [PDF]

Nephrology, 2016
Alastair J Hutchison, Rosamund J Wilson
exaly   +2 more sources

Lanthanum deposition from oral lanthanum carbonate in the upper gastrointestinal tract [PDF]

Histopathology, 2017
Raza S Hoda, Soma Sanyal, Jerrold L Abraham   +2 more
exaly   +2 more sources

Gastropathy associated with lanthanum phosphate deposition that was endoscopically tracked for 3 years. A case report

BMC Gastroenterology, 2020
Background With the recent increased use of lanthanum carbonate, several cases of lanthanum phosphate deposition to gastric mucosa in dialysis patients have been reported.
Akiko Ohno, Jun Miyoshi, Hidesato Tanabe, Mitsunori Kusuhara, Masao Toki, Tomohiro Chiba, Hiroaki Shimoyamada, Junji Shibahara, Tadakazu Hisamatsu   +8 more
doaj   +1 more source

The Pharmacological Effect and Mechanism of Lanthanum Hydroxide on Vascular Calcification Caused by Chronic Renal Failure Hyperphosphatemia

Frontiers in Cell and Developmental Biology, 2021
ObjectiveThe present work aimed to explore the efficacy of lanthanum hydroxide in managing the vascular calcification induced by hyperphosphate in chronic renal failure (CRF) as well as the underlying mechanism.MethodsRats were randomly allocated to five
Lulu Zhao, Shengnan Wang, Hong Liu, Xiaoli Du, Ren Bu, Bing Li, Ruilan Han, Jie Gao, Yang Liu, Jian Hao, Jianrong Zhao, Yan Meng, Gang Li   +12 more
doaj   +1 more source

Novel case of laparoscopically resected gastric adenocarcinoma concurrent with lanthanum deposition

Clinical Case Reports, 2022
A 73‐year‐old man taking lanthanum carbonate for hemodialysis showed progressing gastric mucosal changes with lanthanum deposition. Regular examination revealed concurrent gastric carcinoma.
Kosuke Hirose, Shunichi Saito, Yumi Oshiro, Kazuhito Minami, Koji Ikegami, Koichi Kurahara, Takuya Honbo, Noriaki Sadanaga, Hiroshi Matsuura   +8 more
doaj   +1 more source

Conversion to lanthanum carbonate monotherapy effectively controls serum phosphorus with a reduced tablet burden: a multicenter open-label study

BMC Nephrology, 2011
Background Lanthanum carbonate (FOSRENOL®) is an effective, well-tolerated phosphate binder. The ability of lanthanum to reduce serum phosphorus levels to ≤5.5 mg/dL in patients with end-stage renal disease (ESRD) was assessed in a clinical practice ...
Matalon Albert, Michelis Michael F, Vemuri Nirupama   +2 more
doaj   +1 more source

Lanthanum carbonate versus placebo for management of hyperphosphatemia in patients undergoing peritoneal dialysis: a subgroup analysis of a phase 2 randomized controlled study of dialysis patients

BMC Nephrology, 2013
Background This short-term study assessed the efficacy and safety of lanthanum carbonate in the treatment of hyperphosphatemia in dialysis patients; here, we report a prespecified subgroup analysis of patients undergoing peritoneal dialysis.
Hutchison Alastair J, Gill Maggie, Copley J Brian, Poole Lynne, Wilson Rosamund J   +4 more
doaj   +1 more source

Preparation and Characterization of Lanthanum Carbonate Octahydrate for the Treatment of Hyperphosphatemia

Journal of Spectroscopy, 2013
We proposed a new approach to prepare lanthanum carbonate via reactions between lanthanum chloride and NaHCO3. In the reaction, small amount of NaHCO3 solution was firstly added to the acidic lanthanum chloride solution to generate lanthanum carbonate ...
Anqi He, Fengshan Zhou, Fang Ye, Ying Zhang, Xiren He, Xin Zhang, Ran Guo, Xing Zhao, Yan Sun, Ming Huang, Qin Li, Zhanlan Yang, Yizhuang Xu, Jinguang Wu   +13 more
doaj   +1 more source

Lanthanum carbonate for the treatment of hyperphosphatemia in CKD 5D: multicenter, double blind, randomized, controlled trial in mainland China

BMC Nephrology, 2013
Background Serum phosphorus control is critical for chronic kidney disease (CKD) 5D patients. Currently, clinical profile for an oral phosphorus binder in the mainland Chinese population is not available.
Xu Jing, Zhang Yi-Xiang, Yu Xue-Qing, Liu Zhi-Hong, Wang Li-Ning, Chen Jiang-Hua, Fan Ya-Ping, Ni Zhao-Hui, Wang Mei, Yuan Fa-Huan, Ding Guo-Hua, Chen Xiang-Mei, Zhang Ai-Ping, Mei Chang-Lin   +13 more
doaj   +1 more source